Application of reduced-port laparoscopic total gastrectomy in gastric cancer preserving the pancreas and spleen

Background The feasibility of using reduced-port laparoscopic total gastrectomy (RPLTG) for the treatment of gastric cancer remains unclear. This study aimed to address the potentially important advantages of this surgical technique. Methods Between April 2002 and February 2014, 90 patients underwen...

Full description

Saved in:
Bibliographic Details
Published in:Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2015-10, Vol.18 (4), p.868-875
Main Authors: Kunisaki, Chikara, Makino, Hirochika, Kimura, Jun, Takagawa, Ryo, Ota, Mitsuyoshi, Kosaka, Takashi, Akiyama, Hirotoshi, Endo, Itaru
Format: Article
Language:English
Subjects:
Abdominal Surgery
Adenocarcinoma - surgery
Adult
Aged
Aged, 80 and over
Cancer Research
Female
Gastrectomy - instrumentation
Gastrectomy - methods
Gastric cancer
Gastroenterology
Humans
Laparoscopy - instrumentation
Laparoscopy - methods
Male
Medicine
Medicine & Public Health
Middle Aged
Oncology
Original Article
Pancreas
Spleen
Stomach Neoplasms - surgery
Surgical Oncology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background The feasibility of using reduced-port laparoscopic total gastrectomy (RPLTG) for the treatment of gastric cancer remains unclear. This study aimed to address the potentially important advantages of this surgical technique. Methods Between April 2002 and February 2014, 90 patients underwent laparoscopy-assisted total gastrectomies, performed by a single surgeon. Of these, 45 patients underwent RPLTG and 45 patients underwent conventional laparoscopy-assisted total gastrectomy (CLATG). Short-term outcomes were compared to evaluate the feasibility of RPLTG for gastric cancer. Results There were several significant differences between the RPLTG and CLATG groups in short-term outcomes: the mean total operation durations were significantly longer in the RPLTG group (319.0 min) than in the CLATG group (259.0 min). However, the mean volume of blood loss, the degree of lymph node dissection, and the number of dissected lymph nodes did not differ between the two groups. Conclusions We have shown that RPLTG could be an acceptable and satisfactory procedure for the treatment of gastric cancer requiring total gastrectomy for surgeons sufficiently experienced in CLATG.
ISSN:1436-3291
1436-3305
DOI:10.1007/s10120-014-0441-4